Apple’s Device Delay… And Vaccine Makers Under Pressure 9/12/25
CNBC's "Fast Money"
00:00
IPO Insights and Vaccine Controversies
This chapter explores the recent Gemini IPO, which gained notable institutional interest despite challenges faced by its founders. The discussion also addresses the implications of vaccine manufacturers' controversies and the evolving COVID vaccination recommendations, alongside the effects on public health policies. Additionally, it examines the fluctuating electric vehicle stock market, particularly Tesla's performance and the sentiment among investors, highlighting the complexities of current market dynamics.
Transcript
Play full episode
